期刊論文| 1. | Yeh, T. L.、Chen, K. C.、Lin, S. H.(2012)。Availability of dopamine and serotonin transporters in opioid-dependent users: a two-isotope SPECT study。Psychopharmacology，220，55-64。   |
| 2. | Guilloteau D,、Chalon S.(2005)。PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders。Curr Pharm Des，11，3237-3245。 |
| 3. | Lin SH,、Chen KC,、Yeh TL, et al.(2011)。Striatal dopamine transporter availability correlates with heroin expenditure: a SPECT study。Eur Neuropsychopharmacol，21(3)，576-577。 |
| 4. | Shi J,、Zhao LY,、Copersino ML, et al.(2008)。PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users。Eur J Pharmacol，579，160-166。 |
| 5. | Carlsson, A.、Lindqvist, M.、Magnusson, T.、Waldeck, B.(1958)。On the presence of 3-hydroxytyramine in brain。Science，127，471。 |
| 6. | Verhoeff NP.(1999)。Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders。Psychopharmacology (Berl)，147，217-249。 |
| 7. | Kung MP,、Stevenson DA,、Plossl K, et al.(1997)。[99mTc] TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent。Eur J Nucl Med，24，372-380。 |
| 8. | Mukherjee J,、Yang ZY,、Das MK、Brown T.(1995)。Fluorinated benzamide neuroleptics--III. development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3- [18F]fl uoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer。Nucl Med Biol，22，283-296。 |
| 9. | Kung HF,、Pan S,、Kung MP, et al.(1989)。In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent。J Nucl Med，30，88-92。 |
| 10. | Jia SW,、Wang W,、Liu Y,、Wu ZM.(2005)。Neuroimaging studies of brain corpus striatum changes among heroindependent patients treated with herbal medicine, U’finer capsule。Addict Biol，10，293-297。 |
| 11. | Volkow ND,、Chang L,、Wang GJ, et al.(2001)。Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence。J Neurosci，21，9414-9418。 |
| 12. | Cosgrove KP,、Krantzler E,、Frohlich EB, et al.(2009)。Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking。Neuropsychopharmacology，34，2218-2226。 |
| 13. | Volkow, N. D.、Chang, L.、Wang, G.-J.、Fowler, J. S.、Leonido-Yee, M.、Franceschi, D.、Sedler, M. J.、Gatley, S. J.、Hitzemann, R.、Ding, Y.-S.、Logan, J.、Wong, C.、Miller, E. N.(2001)。Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers。Am J Psychiatry，158(3)，377-382。 |
| 14. | Ebert D,、Klein T,、Lohrmann C,、van Elst LT,、Hesslinger B,、Juengling FD.(2002)。Different striatal dopamine D2 receptor occupancy in alcohol dependent patients with or without physical withdrawal symptoms-- a study using IBZM-SPECT。J Neural Transm，109，1215-1219。 |
| 15. | Repo E,、Kuikka JT,、Bergstrom KA,、Karhu J,、Hiltunen J,、Tiihonen J.(1999)。Dopamine transporter and D2-receptor density in late-onset alcoholism。Psychopharmacology (Berl)，147，314-318。 |
| 16. | Heinz A,、Siessmeier T,、Wrase J, et al.(2004)。Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving。Am J Psychiatry，161，1783-1789。 |
| 17. | Heinz A,、Siessmeier T,、Wrase J, et al.(2005)。Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients。Am J Psychiatry，162，1515-1520。 |
| 18. | Yang, Y. K.、Yao, W. J.、Yeh, T. L.(2008)。Decreased dopamine transporter availability in male smokers--a dual isotope SPECT study。Prog Neuropsychopharmacol Biol Psychiatry，32，274-279。 |
| 19. | Yasuno F,、Ota M,、Ando K, et al.(2007)。Role of ventral striatal dopamine D1 receptor in cigarette craving。Biol Psychiatry，61，1252-1259。 |
| 20. | Takahashi H,、Fujimura Y,、Hayashi M, et al.(2008)。Enhanced dopamine release by nicotine in cigarette smokers: a double-blind, randomized, placebo-controlled pilot study。Int J Neuropsychopharmacol，11，413-417。 |
| 21. | Koob, George F、Le Moal, Michel(1997)。Drug abuse: hedonic homeostatic dysregulation。Science，278，52-58。 |
| 22. | Koob, G. F.、Le Moal, M.(2001)。Drug addiction, dysregulation of reward, and allostasis。Neuropsychopharmacology，24，97-129。 |
| 23. | Volkow ND,、Fowler JS,、Wang GJ,、Baler R,、Telang F.(2009)。Imaging dopamineâs role in drug abuse and addiction。Neuropharmacology，56(1)，3-8。 |
| 24. | Goldstein, R. Z.、Volkow, N. D.(2002)。Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex。American Journal of Psychiatry，159(10)，1642-1652。 |
| 25. | Huang, Hsiang Yu、Lee, I Hui、Chen, Kao Ching、Yeh, Tzung Lieh、Chen, Po See、Yang, Yen Kuang、Chiu, Nan-tsing、Yao, We Jen、Chen, Chia-chieh(20101000)。Association of Novelty Seeking Scores and Striatal Dopamine D₂/D₃ Receptor Availability of Healthy Volunteers: Single Photon Emission Computed Tomography with ¹²³I-iodobenzamide。Journal of the Formosan Medical Association，109(10)，736-739。 |
| 26. | Farde, L,、Gustavsson, J.P.、Jonsson, E.(1997)。D2 dopamine receptors and personality traits。Nature，385(6617)，590。 |
| 27. | Huang CL,、Yang YK,、Chu CL, et al.(2006)。The association between the Lie scale of the Maudsley personality inventory and striatal dopamine D2/D3 receptor availability of healthy Chinese community subjects。Eur Psychiatry，21，62-65。 |
| 28. | Hsieh PC,、Yeh TL,、Lee IH, et al.(2010)。Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers。J Psychiatry Neurosci，35，90-94。 |
| 29. | Guo JF,、Yang YK,、Chiu NT, et al.(2006)。The correlation between striatal dopamine D-2/D-3 receptor availability and verbal intelligence quotient in healthy volunteers。Psychol Med，36，547-554。 |
| 30. | Chen PS,、Yang YK,、Lee YS, et al.(2005)。Correlation between different memory systems and striatal dopamine D-2/D-3 receptor density: a single photon emission computed tomography study。Psychol Med，35，197-204。 |
| 31. | Martinez D,、Orlowska D,、Narendran R, et al.(2010)。Dopamine type 2/3 receptor availability in the striatum and social status in human volunteers。Biol Psychiatry，67，275-278。 |
| 32. | Yeh TL,、Lee IH,、Chen PS, et al.(2009)。Social support and striatal dopaminergic activities: Is there a connection。Prog Neuropsychopharmacol Biol Psychiatry，33，1141-1146。 |
| 33. | Yang YK,、Yeh TL,、Chiu NT, et al.(2004)。Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia。Psychiatry Res，131，209-216。 |
| 34. | Niederhofer H.(2011)。Developing biochemical profiles for various psychiatric diseases。Med Hypotheses，77，532-533。 |
| 35. | Willner P.(1997)。The dopamine hypothesis of schizophrenia: current status, future prospects。Int Clin Psychopharmacol，12，297-308。 |
| 36. | Seeman, P.、Lee, T.、Chau-Wong, M.(1976)。Antipsychotic drug doses and neuroleptic/dopamine receptors。Nature，261，717-719。 |
| 37. | Lyon GJ,、Abi-Dargham A,、Moore H,、Lieberman JA,、Javitch JA,、Sulzer D(2011)。Presynaptic regulation of dopamine transmission in schizophrenia。Schizophr Bull，37，108-117。 |
| 38. | Howes OD,、Montgomery AJ,、Asselin MC, et al.(2009)。Elevated striatal dopamine function linked to prodromal signs of schizophrenia。Arch Gen Psychiatry，66，13-20。 |
| 39. | Karlsson P,、Farde L,、Halldin C,、Sedvall G.(2002)。PET study of D(1) dopamine receptor binding in neurolepticnaive patients with schizophrenia。Am J Psychiatry，159，761-767。 |
| 40. | Yasuno F,、Suhara T,、Okubo Y, et al.(2004)。Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia。Am J Psychiatry，161，1016-1022。 |
| 41. | Talvik M,、Nordstrom AL,、Okubo Y, et al.(2006)。Dopamine D2 receptor binding in drug-naive patients with schizophrenia examined with raclopride-C11 and positron emission tomography。Psychiatry Res，148，165-173。 |
| 42. | Laruelle, M.、Abi-Dargham, A.、Gil, R.、Kegeles, L.、Innis, R.(1999)。Increased dopamine transmission in schizophrenia: relationship to illness phases。Biol Psychiatry，46，56-72。 |
| 43. | Abi-Dargham, A.、Gil, R.、Krystal, J.、Baldwin, R. M.、Seibyl, J. P.、Bowers, M.、Laruelle, M.(1998)。Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort。American Journal of Psychiatry，155，761-767。 |
| 44. | Laruelle, M.(2000)。Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review。J Cereb Blood Flow Metab，20，423-451。 |
| 45. | Guo N,、Guo W,、Kralikova M, et al.(2010)。Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers。Neuropsychopharmacology，35，806-817。 |
| 46. | Kegeles LS,、Abi-Dargham A,、Frankle WG, et al(2010)。Increased synaptic dopamine function in associative regions of the striatum in schizophrenia。Arch Gen Psychiatry，67，231-239。 |
| 47. | Abi-Dargham A,、Rodenhiser J,、Printz D, et al.(2000)。Increased baseline occupancy of D2 receptors by dopamine in schizophrenia。Proc Natl Acad Sci U S A，97，8104-8109。 |
| 48. | Demjaha A,、Murray RM,、McGuire PK,、Kapur S,、Howes OD.(2012)。Dopamine synthesis capacity in patients with treatment-resistant schizophrenia。Am J Psychiatry，169，1203-1210。 |
| 49. | Laakso A,、Bergman J,、Haaparanta M, et al.(2001)。Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia。Schizophr Res，52，115-120。 |
| 50. | Mateos JJ,、Lomena F,、Parellada E, et al.(2007)。Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait。Psychopharmacology (Berl，191，805-811。 |
| 51. | Hsiao, M. C.、Lin, K. J.、Liu, C. Y.、Tzen, K. Y.、Yen, T. C.(2003)。Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1。Schizophr Res，65，39-46。 |
| 52. | Schmitt GJ,、la Fougere C,、Dresel S, et al.(2008)。Dualisotope SPECT imaging of striatal dopamine: fi rst episode, drug naive schizophrenic patients。Schizophr Res，101，133-141。 |
| 53. | Sjoholm H,、Bratlid T,、Sundsfjord J.(2004)。123I-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia。Psychopharmacology (Berl)，173，27-31。 |
| 54. | Chen, K. C.、Yang, Y. K.、Howes, O.(2013)。Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis。Schizophrenia Bulletin，39，378-386。 |
| 55. | Yang YK,、Yu L,、Yeh TL,、Chiu NT,、Chen PS,、Lee IH.(2004)。Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study。Am J Psychiatry，161，1496-1498。 |
| 56. | Okubo, Y.、Suhara, T.、Suzuki, K.(1997)。Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET。Nature，385，634-636。 |
| 57. | Yang YK,、Chiu NT,、Chen CC,、Chen M,、Yeh TL,、Lee IH.(2003)。Correlation between fi ne motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls。Psychiatry Res，123，191-197。 |
| 58. | Kile SJ.(2007)。Neuropsychiatric update: neuroimaging schizophrenia。Psychopharmacol Bull，40，156-167。 |
| 59. | Delgado PL.(2000)。Depression: the case for a monoamine deficiency。J Clin Psychiatry，61(6)，7-11。 |
| 60. | D’Haenen H A,、Bossuyt A(1994)。Dopamine D2 receptors in depression measured with single photon emission computed tomography。Biol Psychiatry，35，128-132。 |
| 61. | Shah PJ,、Ogilvie AD,、Goodwin GM,、Ebmeier KP.(1997)。Clinical and psychometric correlates of dopamine D2 binding in depression。Psychol Med，27，1247-1256。 |
| 62. | Ebert D,、Feistel H,、Loew T,、Pirner A.(1996)。Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy。Psychopharmacology (Berl)，126，91-94。 |
| 63. | Parsey RV,、Oquendo MA、Zea-Ponce Y, et al.(2001)。Dopamine D(2) receptor availability and amphetamine- induced dopamine release in unipolar depression。Biol Psychiatry，50，313-322。 |
| 64. | Hirvonen J,、Karlsson H,、Kajander J, et al.(2008)。Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET。Psychopharmacology (Berl)，197，581-590。 |
| 65. | Argyelan M,、Szabo Z,、Kanyo B, et al.(2005)。Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1。SPECT study. J Affect Disord，89，115-123。 |
| 66. | Brunswick DJ,、Amsterdam JD,、Mozley PD,、Newberg A.(2003)。Greater availability of brain dopamine transporters in major depression shown by [99m Tc] TRODAT-1 SPECT imaging。Am J Psychiatry，160，1836-1841。 |
| 67. | Wu H,、Lou C,、Huang Z,、Shi G.(2011)。SPECT imaging of dopamine transporters with (m)Tc-TRODAT-1 in major depression and Parkinson’s disease。J Neuropsychiatry Clin Neurosci，23，63-67。 |
| 68. | Yang YK,、Yeh TL,、Yao WJ, et al.(2008)。Greater availability of dopamine transporters in patients with major depression- A dual-isotope SPECT study。Psychiatry Research-Neuroimaging，162，230-235。 |
| 69. | Anand A,、Verhoeff P,、Seneca N, et al.(2000)。Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients。Am J Psychiatry，157，1108-1114。 |
| 70. | Berk M,、Dodd S,、Kauer-Sant’anna M, et al(2007)。Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder。Acta Psychiatr Scand Suppl，41-49。 |
| 71. | Yatham LN,、Liddle PF,、Shiah IS, et al.(2002)。PET study of [(18)F]6-fl uoro-L-dopa uptake in neuroleptic-and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium。Am J Psychiatry，159，768-774。 |
| 72. | Yatham LN,、Liddle PF,、Lam RW, et al.(2002)。PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic-and mood-stabilizer-naive patients with nonpsychotic mania。Am J Psychiatry，159，1718-1723。 |
| 73. | Anand A,、Barkay G,、Dzemidzic M, et al.(2011)。Striatal dopamine transporter availability in unmedicated bipolar disorder。Bipolar Disord，13，406-413。 |
| 74. | Chang TT,、Yeh TL,、Chiu NT, et al.(2010)。Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1。Bipolar Disord，12，102-106。 |
| 75. | Solanto MV.(2002)。Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research。Behav Brain Res，130，65-71。 |
| 76. | Spencer TJ,、Biederman J,、Madras BK, et al.(2005)。In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter。Biol Psychiatry，57，1293-1300。 |
| 77. | Volkow ND,、Wang GJ,、Newcorn J, et al.(2007)。Brain dopamine transporter levels in treatment and drug naive adults with ADHD。Neuroimage，34，1182-1190。 |
| 78. | Volkow, N. D.、Wang, G. J.、Kollins, S. H.(2009)。Evaluating dopamine reward pathway in ADHD: clinical implications。JAMA，302，1084-1091。 |
| 79. | Spencer TJ,、Biederman J,、Madras BK, et al.(2007)。Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane。Biol Psychiatry，62，1059-1061。 |
| 80. | Krause KH,、Dresel SH,、Krause J,、Kung HF,、Tatsch K.(2000)。Increased striatal dopamine transporter in adult patients with attention defi cit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography。Neurosci Lett，285，107-110。 |
| 81. | Dresel S,、Krause J,、Krause KH, et al.(2000)。Attention deficit hyperactivity disorder: binding of [99mTc] TRODAT-1 to the dopamine transporter before and after methylphenidate treatment。Eur J Nucl Med，27，1518-1524。 |
| 82. | Ilgin N,、Senol S,、Gucuyener K,、Gokcora N,、Sener S.(2001)。Is increased D2 receptor availability associated with response to stimulant medication in ADHD。Dev Med Child Neurol，43，755-760。 |
| 83. | Hannestad J,、Gallezot JD,、Planeta-Wilson B, et al(2010)。Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo。Biol Psychiatry，68，854-860。 |
| 84. | Lou HC,、Rosa P,、Pryds O, et al.(2004)。ADHD: increased dopamine receptor availability linked to attention defi cit and low neonatal cerebral blood flow。Dev Med Child Neurol，46，179-183。 |
| 85. | da Silva N, Jr.,、Szobot CM,、Anselmi CE, et al.(2011)。Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow。Clin Nucl Med，36，656-660。 |
| 86. | Wise RA.(1996)。Addictive drugs and brain stimulation reward。Annu Rev Neurosci，19，319-340。 |
| 87. | Spanagel, R.、Weiss, F.(1999)。The dopamine hypothesis of reward: past and current status。Trends Neurosci，22，521-527。 |
| 88. | Melis M,、Spiga S,、Diana M.(2005)。The dopamine hypothesis of drug addiction: hypodopaminergic state。Int Rev Neurobiol，63，101-154。 |
| 89. | Miyamoto S,、Duncan GE,、Marx CE,、Lieberman JA.(2005)。Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs。Mol Psychiatry，10，79-104。 |
| 90. | Lin SH,、Chen PS,、Yeh TL,、Yang YK.(2011)。The dopamine hypothesis of social support。Med Hypotheses，77，753-755。 |
| 91. | Howes, O. D.、Kapur, S.(2009)。The dopamine hypothesis of schizophrenia: version III--the final common pathway。Schizophrenia Bulletin，35(3)，549-562。 |
| 92. | Carlsson, A.(1988)。The current status of the dopamine hypothesis of schizophrenia。Neuropsychopharmacology，1，179-186。 |
| 93. | Saunders, R.、Su, T. P.、Breier, A.(1997)。Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method。Proceedings of the National Academy of Sciences of the United States of America，94，2569-2574。 |
| 94. | Farde, L.、Hall, H.、Ehrin, E.、Sedvall, G.(1986)。Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET。Science，231，258-261。 |
| 95. | Previc, Fred H.(1999)。Dopamine and the origins of human intelligence。Brain and Cognition，41，299-350。 |
| 96. | Lee, I. H.、Cheng, C. C.、Yang, Y. K.、Yeh, T. L.、Chen, P. S.、Chiu, N. T.(2005)。Correlation between striatal dopamine D2 receptor density and neuroticism in community volunteers。Psychiatry Research Neuroimaging，138(3)，259-264。 |
| 97. | Cropley, VL、Fujita, M、Innis, RB、Nathan, PJ(2006)。Molecular imaging of the dopaminergic system and its association with human cognitive function。Biol Psychiatry，59，898-907。 |